| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014651 |
| Receipt No. | R000017045 |
| Scientific Title | The effect of ketogenic diet on dementia. |
| Date of disclosure of the study information | 2014/08/01 |
| Last modified on | 2019/08/01 (Ver. 6) |
| Basic information | ||
| Public title | The effect of ketogenic diet on dementia. | |
| Acronym | The effect of ketogenic diet on dementia. | |
| Scientific Title | The effect of ketogenic diet on dementia. | |
| Scientific Title:Acronym | The effect of ketogenic diet on dementia. | |
| Region |
|
|
| Condition | ||
| Condition | Alzheimer's dementia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | We evaluate the effect of ketogenic diet on the cognition in the healthy adults and Alzheimer's disease. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase II,III |
| Assessment | |
| Primary outcomes | The improvement of cognition |
| Key secondary outcomes | The change of molecules for appetite. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Subjects consume a drink containing
emulsified MCTs (20g) or placebo. |
|
| Interventions/Control_2 | Subjects consume emulsified MCTs (20g) twice a day for 2 montths | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Subjects fulfill the NINCDS-ADRDA for alzheimer's disease, and age- and sex-matched healthy volunteers. | |||
| Key exclusion criteria | Participants were excluded if they had a prior medical history | |||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Center of Neurology and Psychiatry | ||||||
| Division name | Department of Mental Disorder Research, National Institute of Neuroscience | ||||||
| Zip code | 187-8502 | ||||||
| Address | 4-1-1, Ogawa-Higashi, Kodaira, Tokyo | ||||||
| TEL | 0423412712 | ||||||
| hkunugi@ncnp.go.jjp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Center of Neurology and Psychiatry | ||||||
| Division name | Department of Mental Disorder Research, National Institute of Neuroscience | ||||||
| Zip code | 187-8502 | ||||||
| Address | 4-1-1, Ogawa-Higashi, Kodaira, Tokyo | ||||||
| TEL | 0423412712 | ||||||
| Homepage URL | http://www.ncnp.go.jp/nin/guide/r3/index.html | ||||||
| ota@ncnp.go.p | |||||||
| Sponsor | |
| Institute | the ethics committee of the National Center of Neurology and Psychiatry |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Comissive research funding from the food science institute foundation |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | The food science institute foundation |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | National Center of Neurology and Psychiatry |
| Address | 4-1-1, Ogawa-Higashi, Kodaira, Tokyo |
| Tel | 0423412711 |
| ota@ncnp.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立精神・神経医療研究センター(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | http://www.ncnp.go.jp/nin/guide/r3/index.html |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | http://www.ncnp.go.jp/nin/guide/r3/index.html | ||||||
| Number of participants that the trial has enrolled | 20 | ||||||
| Results | Twenty patients with AD underwent neurocognitive tests before and after intake of a ketogenic formula. These patients took the ketogenic formula daily for up to 12 weeks, and underwent neurocognitive tests. After the single intake, there was no significant difference, but after the chronic intake of the ketogenic formula, they showed significant improvements in the digit symbol coding test and immediate logical memory test compared with baseline. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | Subjects were 20 patients (11 males; mean age: 73.4 years) who were diagnosed with AD according to the criteria of the NINCDS/ADRDA. |
||||||
| Participant flow | All 20 of these patients participated in the first trial of this study, which examined the possible effect of a single administration of ketogenic formula on cognitive function. For the second trial, which was a longitudinal, open-label 12-week trial, 19 of the 20 patients gave their consent to participate, and 3 dropped out prior to the end of the 12-week administration period. |
||||||
| Adverse events | Three dropped out prior to the end of the 12-week administration period due to diarrhea. |
||||||
| Outcome measures | Immediate logical memory, delayed logical memory, digit span and visual memory span tests from the Wechsler Memory Scale-Revised, block-design and digit symbol coding tests from the Wechsler Adult Intelligence Scale-3rd, the Stroop test and the Trail Making Test. |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017045 |